The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System

by Luqman Jubair, Nigel A.J. McMillan
Published 2017-09-01

Development of novel lipidic particles for siRNA delivery that are highly effective after 12 months storage.

by Daniel Clarke, Adi Idris, Nigel A J McMillan
Published 2019-01-01

CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice.

by Luqman Jubair, Alfred K Lam, Sora Fallaha, Nigel A J McMillan
Published 2021-01-01

Potent inhibition of Hendra virus infection via RNA interference and poly I:C immune activation.

by Jana L McCaskill, Glenn A Marsh, Paul Monaghan, Lin-Fa Wang, Timothy Doran, Nigel A J McMillan
Published 2013-01-01

Liposomal Delivery of miR-34b-5p Induced Cancer Cell Death in Thyroid Carcinoma

by Hamidreza Maroof, Farhadul Islam, LanFeng Dong, Prabha Ajjikuttira, Vinod Gopalan, Nigel A.J. McMillan, Alfred K. Lam
Published 2018-12-01

Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh

by Mushfiq H. Shaikh, Aminul I. Khan, Anwar Sadat, Ahmed H. Chowdhury, Shahed A. Jinnah, Vinod Gopalan, Alfred K. Lam, Daniel T. W. Clarke, Nigel A. J. McMillan, Newell W. Johnson
Published 2017-11-01